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Generally, IgM antibodies (Abs) produced in a primary immune response show lower
affinity for an inducing antigen (Ag) compared with the corresponding IgG Abs that are
major switched isotypes formed in the secondary response. An IgM molecule is a
pentamer with 10 Ag-binding sites that will contribute to an increase of avidity for an
Ag. To estimate the contribution of the pentameric structure to the avidity of an IgM
Ab, we generated IgM and IgG I monoclonal Abs (mAbs) with identical V regions that
are specific for 4-hydroxy-3-nitrophenylacetyl (NP) by in vitro class switching of B
cells followed by the cell fusion with a mouse myeloma cell line. Compared with an
anti-NP IgG I mAb, the corresponding IgM mAb showed much higher avidity for NP-
conjugated bovine serum albumin, which was drastically reduced after being dissociated
into monomers.
1. Introduction
During a T cell-dependent Ab response, the isotype of produced Abs is switched
from IgM to other classes including IgG with time after immunization (I). Another
characteristic feature is a gradual increase of Ab affinity for an inducing Ag particularly
in the switched isotypes, a process termed affinity maturation (1-3). It has been shown
that isotype-switching and affinity maturation are strongly dependent on genninal
centers (GC) that are transiently formed from Ag-stimulated B cells and CD4+ T cells in
the follicular region of secondary lymphoid tissues (1,2). Affinity maturation of Abs
is the result of somatic hypermutation of V region genes coupled with the positive
selection of B cells whose mutated B cell antigen receptors (BCR) acquire higher
affinity, (1,4). In general, IgG Abs have point mutations in the V region more
frequently than the corresponding IgM Abs, and the former isotype shows higher
affinity for the inducing Ag than the latter (4). Recent discovery of activation-induced
cytidine deaminase (AID) that is essential for both class switching and somatic
hypermutation has enabled us to understand the coordinated occurrence of these two
processes (5).
For estimating the binding strength of an Ab to an Ag, one has to measure not
only the affinity of each Ag-binding site for an antigenic epitope, but also the binding
activity taking into account the valency of the interaction, termed avidity. Therefore,
avidity, instead of affinity, generally reflects the precise binding strength of an Ab.
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Although each Ag-binding site in an IgM molecule generally shows low affinity for an
Ag, this is considered to be somewhat compensated by its pentameric structure that
contribute to increase the avidity. Thus, class switching to IgG without somatic
mutations, if it occurs, will result in the formation of useless Abs with low avidity.
To examine to what extent the pentameric structure of IgM is responsible for its
avidity. we generated IgM and IgG I mAbs that bear a common V region in the heavy
chain (VH) and that in the light chain (VL), and compared these two mAbs for the
binding to the relevant Ag. As a B cell source, we used the quasi-monoclonal (QM)
mouse, in which one of the JH loci is replaced with the VHDJH segment (VHT) derived
from an anti-NP IgG mAb, 17.2.25, with the other JH locus and both K loci being
disrupted (6). Thus, approximately 80% of QM B cells expressed VHT-encoded NP-
specific BCR that bear A cbains exclusively (6,7).
2. Materials and Methods
QM mice were generously given by Dr. Marilia Cascalho (Mayo Clinic, Rochester, MN,
USA). To induce class switching without causing somatic mutations, QM B cells
were cultured in vitro for 5 days with 20 flg/mJ of lipopolysaccharide (LPS) from
Escherichia coLi (Sigma, SI. Louis, MO, USA) and 10 ng/ml of interleukin (lL)-4
(Peprotech, Princeton, NJ, USA), followed by the cell fusion with a mouse myeloma
cell line, NSObd.2 as the fusion partner (8,9). NSOoc',' is advantageous in generating
hybridomas efficiently since the transfected bcl-2 gene is expected to rescue
hybridomas from apoptosis (9). Among hybridomas secreting anti-NP IgM or anti-NP
IgG mAbs. an IgM-secretor and an IgG I-secretor that used the VHT-encoded !-t or YI
chain paired with the A2 L chain were selected by using a rat mAb, R2.438 that is
specific for the idiotype of VHT-encoded H chains (a gift from Dr. T. Imanishi-Kari,
Tufts University, Boston, MA) and by anti-mouse A2 mAb (Pharrningen, San Diego,
CAl. In some cases, the use of the A2 chain was confirmed by A2-specific
reversetranscription-dependent PCR as described (7). We sequenced the VH and the
VL genes in these two mAhs as described previously (7), and confirmed that there was
no point mutation in the VH as well as the VA2 gene as expected (Fig. I). The culture
supernatants of the hybridomas or mAbs that were purified from the hybridoma ascites
by an affinity chromatography on a NP-conjugated Sepharose 4B column were used as
test samples.
For preparing NP-conjugated bovine serum albumin (NP-BSA), 4-hydroxy-3-
nitrophenylacetic acid (Tokyo Kasei, Tokyo, Japan) was converted to the N-
hydroxysuccinimide ester, and then reacted with BSA for 3-90 min as described
previously (7). Low and high-density NP-BSA that bear 3 and 25 NP moieties per BSA
molecule, designated as NP3-BSA and NP,,-,-BSA, respectively, were prepared. The
high-density NP-BSA binds low-affinity anti-NP Abs as efficiently as the high-affinity
Abs, while the low-density NP-BSA reacts preferentially with the high-affinity Abs, but
poorly with the low-affinity Abs (10). Thus, anti- NP Ab affinity can be estimated by
comparing the binding of the Ab to NP3-BSA and NP25-BSA (11).
Varying concentrations of the anti-NP IgM and IgG 1 mAbs were incubated for 2
h in the 96 well microplates (NUNC, Roskilde, Denmark) that were coated with 4 flg/mJ
of NP,-BSA or NP25-BSA followed by blocking with 1 mg/ml BSA in phosphate-
buffered saline (PBS). After washing thoroughly with PBS, bound anti-NP mAbs
were determined by reacting with 1 !-tg/mJ peroxidase-conjugated goat anti-mouse IgM
or IgG 1 as the second Ab (Southern Biotechnology Associates, Birmingham, AL).
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V.T 1 :GAGGTICAGCTGCAGCAGT CTGGGGCAGAGcnGTGAAGCCAGGGGCCTCAGTCAAGTIG
CDR!
61 :TCCTGCACAGcnCTGGcnCAACATIMAGACACCTATATGCACTGGGTGAAGCAGAGG
CDR2
121:CCTGAACAGGGCCTGGAGTGGATIGGAAGGATIGATCCTGCGAATGGTAATACTMATAT
181:GACCCGAAGTICCAGGGCAAGGCCACTATAACAGCAGACACATCCTCCAACACAGCCTAC
D8p2.3
241: CTGCAGCTCAGCAGCCTGACATCTGAGGACACTGCCGTCTATIACTGTGCTAGATACTAT
JB4
301:AGGTACCcnACTATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA
Vi,2 1: CAGGCTGTT GTGACTCAGGAATCTGCACTCACCACAT CACCTGGTGGAACAGTCATACTC
CDRl
61 :ACTIGTCGCTCAAGTACTGGGGCTGTIACAACTAGTAACTATGCCAACTGGGTCCAAGAA
CDR2
120:MACCAGATCATTIATICACTGGTCTAATAGGTGGTACCAGCAACCGAGCTCCAGGTGTI
180: CCTGTCAGATICTCAGGCTCCCTGATIGGAGACAAGGCTGCCCTCACCATCACAGGGGCA
Ji.2
241:CAGACTGAGGATGATGCAATGTATTICTGTGCTCTATGGTACAGCACCCATIATGTTTIC
301:GGCGGTGGAACCAAGGTCACTGTCCTAG
Fig. 1. VH and VL nucleotide sequences in anti-NP IgM and IgG1 mAbs.
The A.2L chain was used in either mAb.
The bound peroxidase activity was assayed using 2,2'-azino-bis (3-
ethylbenzthiazoline)-6-sulfonic acid as the substrate (8). Unless otherwise stated, all
incubations were carried out at 25°C. Data were presented as mean values from
triplicate experiments with standard errors, which did not usually exceed 5% of the
mean, and are often invisible in the figures.
3. Results and Discussion
As shown in Fig. 2, approximately the same dose-response curves were observed in the
binding of the anti-NP IgM mAb to either plates, while the anti-NP IgG1 mAb bound to
NPo,-BSA-coated plates significantly, but not to plates coated with NPJ-BSA at the Ab
concentrations tested. These results suggest that the IgM mAb showed stronger
binding (higher avidity) to NP-BSA than the IgG I counterpart. Because identical VH
and VL genes encode the Ag-binding site in these two mAbs, the superiority of the IgM
over the IgG 1 may be due to that IgM has a pentameric structure that bear ten Ag-
binding sites, while there are only two Ag-binding sites in an IgG I molecule. The
contribution of the oligomeric structure to an increase in the avidity was further
analyzed in the following experiments.
A displacement ELISA was carried out to confirm the higher avidity of the anti-
NP IgM mAb in the dissociation reaction. The anti-NP IgM or IgG 1 mAbs were
incubated at 200 ng/ml for 1 h in an NPos-BSA-coated microplate, followed by washing.
Then, varying concentrations of free NP-E-aminocaproate were added in each well, and
incubated for I h. After removing dissociated Abs by washing, residual mAbs were
determined as described above. The anti-NP IgG I mAb was displaced by much lower
concentrations of NP-E-aminocaproate than those required for the displacement of the
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IgM counterpart (Fig. 3). The concentration of NP-E-aminocaproate that caused 50%
displacement was estimated to be I x to-3M for the anti-NP IgM mAb and 5 x lO-sM for
the anti-NP IgG I mAb, respectively, thus showing again that the IgM has higher avidity
for NP-BSA than the corresponding IgG 1.
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Fig. 2. Binding of the anti-NP IgM (circles) and IgGl (triangles) mAbs to
microplates that were coated with NP3-BSA (left panel) or NPz,-BSA (right panel).
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Fig. 3. Displacement by free NP of the anti-NP IgM and IgG 1 mAbs that bound to
NPzs-BSA-coated microplates. Varying concentrations of NP-E-aminocaproate was
added in each well to displace the bound anti-NP IgM (circles) or anti-NP IgG 1
(triangles) mAbs. Data were presented as relative values, where the binding in the
absence of the free NP was expressed as 100.
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To estimate the role of the pentameric structure in the avidity of anti-NP IgM
mAb, the IgM was dissociated into monomers by the treatment with 2-mercaptoethanol
(2-ME) (10). Anti-NP IgM or IgG I mAb (10 pg/ml) was treated with 1 M 2-ME at 37
°C for 2 h in PBS containing 4 mM EDTA, and examined for the binding to NP,,-BSA-
coated plates at varying concentrations (Fig. 4). The 2-ME-treatment did not
significantly affect the binding of the IgG 1 mAb, suggesting minimal effects of 2-ME
on the conformation of the Ag-binding sites. In contrast, the binding of
the anti-NP IgM mAb was drastically reduced by the 2-ME-treatment to the level that is
comparable to or a little lower than that of the IgG 1. The monomeric anti-NP IgM
showed more than 1000-fold reduced binding to NP-BSA compared with the
pentameric form. Thus, our results indicate that the pentameric structure of an IgM
molecule plays an important role in the binding to an Ag by increasing avidity. A set
of mAbs belonging to various isotypes that bear a common V region have been isolated
from a lymphoma patient (12), or obtained as spontaneous class switch variants of
hybridomas (13,14). In the former case, anti-tubulin mAbs of the IgA and IgM classes
showed higher affinity than the IgG I counterpart. The authors have suggested that not
only the polyvalency but also the interaction between the V region and the Fc portion
may modulate the Ag-binding capacity (12). This can not be ruled out in our
experiments either because the monomeric form of the IgM mAb showed a little weaker
affinity than the corresponding IgG lmAb (Fig. 4).
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Fig. 4. Effects of 2-ME-treatment on the avidity of anti-NP mAbs. Anti-NP IgM
(circles) and IgG I (triangles) mAbs were treated with 1 M 2-ME (closed symbols) or
left untreated (open symbols) as described in the text, and assayed for the binding to
NP,,-BSA-coated plates.
In conclusion, the polyvalency in IgM Abs may playa crucial role in improving
avidity by increasing the density of Ag-binding sites. Affinity maturation of IgG Abs
is considered to be the process in which a great loss of avidity during class switching to
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IgG is compensated by somatic hypermutation of V genes coupled with the positive
selection of mutated B cells.
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